PsiOxus Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:$84.1M
Lead Investor(s):N/A

Estimated Revenue & Financials

  • PsiOxus Therapeutics's estimated annual revenue is currently $19.8M per year.(?)
  • PsiOxus Therapeutics's estimated revenue per employee is $155,000
  • PsiOxus Therapeutics's total funding is $84.1M.

Employee Data

  • PsiOxus Therapeutics has 128 Employees.(?)
  • PsiOxus Therapeutics grew their employee count by 27% last year.
  • PsiOxus Therapeutics currently has 1 job openings.

PsiOxus aims to be the world's leading cancer gene therapy company, delivering medicines of value to patients with cancer. We focus on discovering and developing innovative gene-based immuno-oncology treatments for solid tumors using our proprietary intravenously administered T-SIGn virus platform. Our portfolio of differentiated gene therapy products are all delivered systemically but act locally within the tumor. At PsiOxus we are advancing our internal early and clinical stage candidates and establishing strategic partnerships with immuno-oncology leaders to bring our cancer gene therapy products to patients. Find our more about us at

keywords:Biotechnology,Healthcare,Medical Diagnostics,Pharmaceuticals